These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 2139861)

  • 1. Ovarian response and pregnancy rates in in vitro fertilization, gamete intrafallopian transfer, and in vivo fertilization therapies after combined gonadotropin-releasing hormone agonist/human menopausal gonadotropin stimulation.
    Lindner C; Braendle W; Lichtenberg V; Köhler S; Bettendorf G
    Gynecol Obstet Invest; 1990; 29(2):140-4. PubMed ID: 2139861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Increased incidence of ovarian hyperstimulation syndrome following combined GnRH agonist/hMG therapy].
    Lindner C; Braendle W; Köhler S; Bettendorf G
    Geburtshilfe Frauenheilkd; 1989 Apr; 49(4):337-44. PubMed ID: 2525500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of long-acting gonadotropin-releasing hormone agonist (GnRH-a; decapeptyl) and gonadotropins versus short-acting GnRH-a (buserelin) and gonadotropins before and during ovarian stimulation for in vitro fertilization (IVF).
    Gonen Y; Dirnfeld M; Goldman S; Koifman M; Abramovici H
    J In Vitro Fert Embryo Transf; 1991 Oct; 8(5):254-9. PubMed ID: 1836810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled study of gonadotropin-releasing hormone agonist (buserelin acetate) for folliculogenesis in routine in vitro fertilization patients.
    Polson DW; MacLachlan V; Krapez JA; Wood C; Healy DL
    Fertil Steril; 1991 Sep; 56(3):509-14. PubMed ID: 1909978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined GnRH analogs/hMG/hCG treatment].
    Braendle W
    Arch Gynecol Obstet; 1989; 245(1-4):931-5. PubMed ID: 2529828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in in vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins.
    Herman A; Ron-El R; Golan A; Raziel A; Soffer Y; Caspi E
    Fertil Steril; 1990 Jan; 53(1):92-6. PubMed ID: 2104811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do the suppression criteria in GnRH-a cycles predict in vitro fertilization outcome?
    Senöz S; Gülekli B; Turhan NO; Ozakşit G; Odabaşi AR; Oral H; Ozcan U; Gökmen O
    Gynecol Endocrinol; 1995 Jun; 9(2):91-6. PubMed ID: 7502695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of human menopausal gonadotropin and follicle-stimulating hormone with gonadotropin-releasing hormone agonist desensitization for controlled ovarian hyperstimulation in in vitro fertilization.
    Yang TS; Wang BC; Chang SP; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jun; 55(6):452-6. PubMed ID: 7634183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ovarian stimulation regimens for in vitro fertilization (IVE) with and without a gonadotropin-releasing hormone (GnRH) agonist: results of a randomized study.
    van de-Helder AB; Helmerhorst FM; Blankhart A; Brand R; Waegemaekers C; Naaktgeboren N
    J In Vitro Fert Embryo Transf; 1990 Dec; 7(6):358-62; discussion 363-4. PubMed ID: 2127604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and follicular fluid (FF) estradiol (E2) levels in ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF) and gamete intrafallopian transfer (GIFT) conception cycles after pituitary suppression.
    Leya J; Molo MW; Olson D; Radwanska E
    J In Vitro Fert Embryo Transf; 1991 Jun; 8(3):137-40. PubMed ID: 1919258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined treatment with a GnRH-analog and gonadotropins in IVF-ET/GIFT patients after previously unsuccessful pure HMG stimulation].
    Urbancsek J; Rabe T; Grunwald K; Thuro H; Runnebaum B
    Zentralbl Gynakol; 1991; 113(10):563-74. PubMed ID: 1927104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization: a European series and a proposal for prevention.
    Forman RG; Frydman R; Egan D; Ross C; Barlow DH
    Fertil Steril; 1990 Mar; 53(3):502-9. PubMed ID: 2106456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian stimulation with gonadotropin-releasing hormone (GnRH) analogue improves the in vitro fertilization (IVF) pregnancy rate with both transvaginal and laparoscopic oocyte recovery.
    Dor J; Ben-Shlomo I; Lipitz S; Levran D; Etchin A; Rudak E; Mashiach S
    J In Vitro Fert Embryo Transf; 1990 Dec; 7(6):351-4. PubMed ID: 2150203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study of the controlled ovarian hyperstimulation using GnRH agonist and pure FSH in in vitro fertilization-embryo transfer and gamete intrafallopian transfer program].
    Usui A
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1431-8. PubMed ID: 2511261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropins for in vitro fertilization or gamete intrafallopian transfer.
    Ferrier A; Rasweiler JJ; Bedford JM; Prey K; Berkeley AS
    Fertil Steril; 1990 Jul; 54(1):90-5. PubMed ID: 2113492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective randomized study of human menotropin versus a follicular and a luteal phase gonadotropin-releasing hormone analog-human menotropin stimulation protocols for in vitro fertilization.
    Maroulis GB; Emery M; Verkauf BS; Saphier A; Bernhisel M; Yeko TR
    Fertil Steril; 1991 Jun; 55(6):1157-64. PubMed ID: 1903732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leuprolide acetate-prepared in vitro fertilization-gamete intrafallopian transfer cycles: efficacy versus controls and cost analysis.
    Corson SL; Batzer FR; Gocial B; Eisenberg E; Huppert LC; Nelson JR
    Fertil Steril; 1992 Mar; 57(3):601-5. PubMed ID: 1740205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization.
    Tan SL; Kingsland C; Campbell S; Mills C; Bradfield J; Alexander N; Yovich J; Jacobs HS
    Fertil Steril; 1992 Apr; 57(4):810-4. PubMed ID: 1555692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed occurrence of an LH surge after HCG administration during ovarian stimulation with gonadotrophins: effect of LHRH treatment.
    Rojas FJ; Moretti-Rojas I; Balmaceda JP; Asch RH
    Hum Reprod; 1989 Aug; 4(6):643-6. PubMed ID: 2506219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression with gonadotropin-releasing hormone analogues prior to stimulation with gonadotropins: comparison of three protocols.
    Lipitz S; Ben-Rafael Z; Dor J; Shalev J; Elenbogen A; Levran D; Serr DM; Mashiach S
    Gynecol Obstet Invest; 1989; 28(1):31-4. PubMed ID: 2528497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.